EN
All Categories
EN

Ule Nlekọta Nlekọta

Glu HCY UA LDL-C - Chronic Disease Screening Rapid Reagent Kit

Easy of operation, fully automatic,

Ọ dịghị mkpa ọrụ ọrụ / mmezi


Overview

[email protected] The Glucose/Homocysteine/Uric Acid/Low Density Lipoprotein Cholesterol Reagent kit is intended to quantitatively determine the concentration of glucose (Glu), homocysteine (HCY), uric acid (UA) and low density lipoprotein cholesterol (LDL-C) in human serum. Clinically, it is mainly used for the monitoring of blood glucose level, auxiliary diagnosis of hyperhomocysteinemia, hyperuricemia, hypercholesteremia, coronary heart disease, atherosclerosis and the risk evaluation of cardiovascular diseases.


Ihe eji eme

The glucose concentration in serum reflects the status of glycemic control in real-time. Strict control of blood glucose level is essential in the prevention and treatment of blood glucose disorder such as diabetes.

Homocysteine is one of independent risk factors for the development of stroke, coronary arteriosclerosis and myocardial infarction, where high levels of homocysteine increases the risk of developing the diseases. Meanwhile, according to its metabolism feature, homocysteine concentration is also a sensitive indicator of vitamin B12 deficiency and folic acid deficiency.

UA is the end product of the metabolic breakdown of purines, and is filtered out of human body through kidney and in urine. In normal condition, the uric acid level in human body is in dynamic equilibrium. Elevated uric acid level is normally observed in patients with renal diseases. Thus, UA measurement is used as an aid in the diagnosis of early-stage renal injury.

Low density lipoprotein cholesterol can reflect the level of low density lipoprotein, which is also known as an atherogenic factor. Higher ratio of low density lipoprotein cholesterol among total cholesterol indicates increased risk of atherosclerosis. The precise measurement of low density lipoprotein cholesterol is significant in early prevention, diagnosis, treatment and curative effect of coronary heart disease, and is the main reference basis of prescription determination for hyperlipoproteinemia patients.


Product Atụmatụ

Usoro mmeghachi omume nke mmiri, na-eji usoro enzymatic na-eduga na nsonaazụ ziri ezi

Nsonaazụ dị na nkeji 12

Katrijị jupụtagoro na nke mbụ

Easy nke ime ihe, n'ụzọ zuru ezu akpaka, ọ dịghị mkpa ọrụ ọrụ / mmezi

8


nkọwapụta

Ihe nyocha

Glu/HCY/UA/LDL-C

Ngwa

Ọbara ọbara

Oge mmeghachi omume

12 nkeji

Atụ Range

Glu: 1.0 ~ 30.0 mmol / L.

HCY: 3.0~50.0 µmol/L

UA: 50~2500 µmol/L

LDL-C: 0.3 ~ 10 mmol / L.

iru eru

CE



Kpọtụrụ Anyị